Literature DB >> 11812019

Neuroendocrine mechanisms in fibromyalgia-chronic fatigue.

D Buskila1, J Press.   

Abstract

Fibromyalgia and chronic fatigue syndrome are poorly understood disorders that share similar demographic and clinical characteristics. Because of the clinical similarities between both disorders it was suggested that they share a common pathophysiological mechanism, namely, central nervous system dysfunction. This chapter presents data demonstrating neurohormonal abnormalities, abnormal pain processing and autonomic nervous system dysfunction in fibromyalgia and chronic fatigue syndrome. The possible contribution of the central nervous system dysfunction to the development and symptomatology of these conditions is discussed. The chapter concludes by reviewing the effect of current treatments and emerging therapeutic modalities in fibromyalgia and chronic fatigue syndrome. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11812019     DOI: 10.1053/berh.2001.0191

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  6 in total

1.  Modeling diurnal hormone profiles by hierarchical state space models.

Authors:  Ziyue Liu; Wensheng Guo
Journal:  Stat Med       Date:  2015-07-07       Impact factor: 2.373

2.  Chronic fatigue syndrome defies the mind-body-schism of medicine. New perspectives on a multiple realisable developmental systems disorder.

Authors:  Elling Ulvestad
Journal:  Med Health Care Philos       Date:  2008-02-21

Review 3.  Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications.

Authors:  Dan Buskila; Joseph Press; Mahmoud Abu-Shakra
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

Review 4.  Advances in diagnostic and treatment options in patients with fibromyalgia syndrome.

Authors:  Ali Gur; Pelin Oktayoglu
Journal:  Open Access Rheumatol       Date:  2009-12-09

Review 5.  An Association of Serotonin with Pain Disorders and Its Modulation by Estrogens.

Authors:  Stephania Paredes; Santiago Cantillo; Kenneth D Candido; Nebojsa Nick Knezevic
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

6.  Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome.

Authors:  J H Raphael; J L Southall; G J Treharne; G D Kitas
Journal:  BMC Musculoskelet Disord       Date:  2002-09-08       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.